glp 1 drugs blindness Does Ozempic Cause Blindness? [2026 Update] Blindness and GLP-1 Drugs: An

Yu M, Moreno C, Hoagland KM, Dahly A, Ditter K, Mistry M, et al

Directions for Future Research: Investigations should focus on confirming the efficacy of tirzepatide in type 1 diabetes, elucidating the neuroprotective potential of GLP-1/GIP dual agonists, optimizing perioperative protocols, and facilitating the clinical translation of novel multi-receptor agonists

Cancellation takes effect at the end of the current billing period

In the Satiety and Clinical AdiposityLiraglutide Evidence (SCALE) Diabetes trial, a total of 846 overweight and obese patients with T2D were randomly assigned to receive 3.0 or 1.8 mg of liraglutide or placebo for 56 weeks